Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biofil financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥14.3
2024-10-29
Market Capitalization
¥1.9 B
2024-10-29
Revenue
¥521 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 202.8M | 243.0M | 494.9M | 843.7M | 596.1M | 442.6M | 521.0M |
| Cost of goods sold | 115.8M | 136.9M | 270.5M | 497.0M | 415.6M | 321.3M | 327.3M |
| Gross profit | 89.1M | 108.4M | 230.1M | 355.1M | 186.6M | 135.0M | 221.5M |
| Gross profit margin, % | 44.6% | 46.5% | 42.1% | 31.3% | 30.5% | 42.5% | |
| Operating expense total | 37.7M | 32.7M | 46.3M | 70.8M | 35.5M | 33.8M | 57.9M |
| Depreciation and amortization | 503.0K | 11.6M | 27.4M | 66.7M | 57.5M | 53.6M | 52.6M |
| EBITDA | 51.4M | 75.7M | 183.8M | 284.3M | 149.5M | 101.3M | 162.6M |
| EBITDA margin, % | 31.2% | 37.1% | 33.7% | 25.1% | 22.9% | 31.2% | |
| EBIT | 59.2M | 72.8M | 147.1M | 199.7M | 92.5M | 44.2M | 109.2M |
| EBIT margin, % | 30.0% | 29.7% | 23.7% | 15.5% | 10.0% | 21.0% | |
| Interest income | 43.0K | 130.0K | 10.8M | 4.8M | 8.1M | 14.4M | 14.5M |
| Interest expense | 136.0K | 3.0K | 1.1M | 12.9M | 24.8M | 26.4M | |
| Pre tax profit | 61.3M | 76.4M | 147.8M | 195.6M | 98.0M | 38.3M | 95.6M |
| Income tax expense | 8.5M | 10.2M | 28.4M | 24.5M | 10.3M | 3.2M | 22.7M |
| Net Income | 52.8M | 66.2M | 119.4M | 171.2M | 87.7M | 35.1M | 73.0M |